BRIEF-Amneal Pharma To Settle Majority Of Opioids-Related Claims

Reuters01-29

Jan 28 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O:

AMNEAL PHARMA - TO SETTLE MAJORITY OF OPIOIDS-RELATED CLAIMS - SEC FILING
AMNEAL PHARMA - OPIOIDS SETTLEMENT AGREEMENT EFFECTIVE JANUARY 29, 2026 - SEC FILING
AMNEAL PHARMA - TO PAY $88.5 MILLION UNDER OPIOIDS SETTLEMENT - SEC FILING
AMNEAL PHARMA - TO PROVIDE $177.4 MILLION IN NALOXONE NASAL SPRAY TO HELP TREAT OPIOID OVERDOSES - SEC FILING

Further company coverage: AMRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2607472870?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 05:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607472870","market":"fut","top_or_hot":-1,"title":"BRIEF-Amneal Pharma To Settle Majority Of Opioids-Related Claims","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Amneal Pharma To Settle Majority Of Opioids-Related Claims</title></head><body><p><span>Jan 28 (Reuters)</span><span> - </span>Amneal Pharmaceuticals Inc <span>AMRX.O</span>:</p><ul><li><p>AMNEAL PHARMA - TO SETTLE MAJORITY OF OPIOIDS-RELATED CLAIMS - SEC FILING</p></li><li><p>AMNEAL PHARMA - OPIOIDS SETTLEMENT AGREEMENT EFFECTIVE JANUARY 29, 2026 - SEC FILING</p></li><li><p>AMNEAL PHARMA - TO PAY $88.5 MILLION UNDER OPIOIDS SETTLEMENT - SEC FILING</p></li><li><p>AMNEAL PHARMA - TO PROVIDE $177.4 MILLION IN NALOXONE NASAL SPRAY TO HELP TREAT OPIOID OVERDOSES - SEC FILING</p></li></ul><p>Further company coverage: <span>AMRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Amneal Pharma To Settle Majority Of Opioids-Related Claims</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Amneal Pharma To Settle Majority Of Opioids-Related Claims\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-29 05:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Amneal Pharma To Settle Majority Of Opioids-Related Claims</title></head><body><p><span>Jan 28 (Reuters)</span><span> - </span>Amneal Pharmaceuticals Inc <span>AMRX.O</span>:</p><ul><li><p>AMNEAL PHARMA - TO SETTLE MAJORITY OF OPIOIDS-RELATED CLAIMS - SEC FILING</p></li><li><p>AMNEAL PHARMA - OPIOIDS SETTLEMENT AGREEMENT EFFECTIVE JANUARY 29, 2026 - SEC FILING</p></li><li><p>AMNEAL PHARMA - TO PAY $88.5 MILLION UNDER OPIOIDS SETTLEMENT - SEC FILING</p></li><li><p>AMNEAL PHARMA - TO PROVIDE $177.4 MILLION IN NALOXONE NASAL SPRAY TO HELP TREAT OPIOID OVERDOSES - SEC FILING</p></li></ul><p>Further company coverage: <span>AMRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1BW:1","article_id":"2607472870","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607472870","pubTimestamp":1769635601,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Amneal Pharma To Settle Majority Of Opioids-Related ClaimsJan 28  - Amneal Pharmaceuticals Inc AMRX.O:AMNEAL PHARMA - TO SETTLE MAJORITY OF OPIOIDS-RELATED CLAIMS - SEC FILINGAMNEAL PHARMA - OPIOIDS SETTLEMENT AGREEMENT EFFECTIVE JANUARY 29, 2026 - SEC FILINGAMNEAL PHARMA - TO PAY $88.5 MILLION UNDER OPIOIDS SETTLEMENT - SEC FILINGAMNEAL PHARMA - TO PROVIDE $177.4 MILLION IN NALOXONE NASAL SPRAY TO HELP TREAT OPIOID OVERDOSES - SEC FILINGFurther company coverage: AMRX.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","AMRX":"Amneal Pharmaceuticals, Inc."},"translate_title":"简介-Amneal Pharma将解决大部分与阿片类药物相关的索赔","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMRX":0.9},"content_text":"BRIEF-Amneal Pharma To Settle Majority Of Opioids-Related ClaimsJan 28 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O:AMNEAL PHARMA - TO SETTLE MAJORITY OF OPIOIDS-RELATED CLAIMS - SEC FILINGAMNEAL PHARMA - OPIOIDS SETTLEMENT AGREEMENT EFFECTIVE JANUARY 29, 2026 - SEC FILINGAMNEAL PHARMA - TO PAY $88.5 MILLION UNDER OPIOIDS SETTLEMENT - SEC FILINGAMNEAL PHARMA - TO PROVIDE $177.4 MILLION IN NALOXONE NASAL SPRAY TO HELP TREAT OPIOID OVERDOSES - SEC FILINGFurther company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2607472870","isCrawlerRequest":true}